ali eskandar
ali eskandar

@alieskandar

9 Tweets 4 reads May 17, 2021
Thread
I would like to discuss “Fluoroquinolone (FQ) or TMP-SMX vs beta-lactam (BLs) after initial IV course for gram negative bacteremia (GNR) “
Systemic review was conducted and eight retrospective studies met the inclusion criteria
@IdVilchez
There was 2289 patients 65% transitioned to FQ , 7.7 % transitioned to TMP-SMX, and 27.2 % to BLs.
Follow up ranged between 21 and 90 days .
All cause mortality was not different but recurrent of bacteremia or infection at the primary site was more noted in BLs vs FQs
(OR, 2.05; 95% CI, 1.17–3.61).
The argument for BLs is the dose was suboptimal , BLs exhibit time dependent inhibition and killing and it is generally recommended to target a free drug concentration time greater than the minimum inhibitory concentration
(MIC; fT > MIC) of >50% for penicillins and 60% for cephalosporins.Some BLs have excellent bioavailability include amoxicillin has up to 92%, amoxicillin/clavulanate 60%, cephalexin up to 100%, and cefaclor up to 95% bioavailability,
whereas ciprofloxacin has 85% and TMP-SMX has 90% bioavailability .
Dosing regimen recommended include
amoxicillin be dosed at 1 g every 8 hours, and cephalexin at 1 g every 6 hours, high-dose amoxicillin and
amoxicillin/clavulanate should be used and dosed every 8 hours for treating serious infections.
What is your experience with the BLs regimens mentioned above ?
Would you even give higher doses on morbidly obese patients ?
Thank you

Loading suggestions...